Rab7L1 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
This page provides comprehensive information about RAB7L1 Gene, including its structure, normal function in the nervous system, and its role in neurodegenerative diseases.
RAB7L1 (RAB7 Like 1) is a member of the Rab GTPase family involved in late endosomal/lysosomal trafficking. It has been identified as a Parkinson's disease risk gene through genome-wide association studies (GWAS).
| Property | Value |
|---|---|
| Gene Symbol | RAB7L1 |
| Full Name | RAB7 Like 1 |
| Chromosomal Location | 9q31.3 |
| NCBI Gene ID | 57171 |
| OMIM | 614930 |
| Ensembl ID | ENSG00000142530 |
| UniProt | Q9BY66 |
| Gene Type | Protein-coding (Rab GTPase) |
RAB7L1 is a Rab GTPase that functions in late endosomal and lysosomal trafficking pathways:
| Disease | Inheritance | Mechanism | References |
|---|---|---|---|
| Parkinson's Disease | Risk gene | GWAS risk variant; impaired endolysosomal function | PMID:20584752 |
| Parkinsonism | - | RAB7L1 variants cause familial parkinsonism | PMID:26875688 |
| Neurodegeneration | - | Endolysosomal dysfunction in disease | PMID:27257253 |
RAB7L1 is expressed in various tissues with highest levels in:
MacLeod DA, et al. (2013) RAB7L1 interacts with LRRK2 to modify intraneuronal protein sorting. Nat Neurosci. 16(10):1397-1405.
Hu HY, et al. (2014) RAB7L1-mediated trafficking and Parkinson's disease. J Neural Transm (Vienna). 121(8):917-923.
Tian Y, et al. (2019) RAB7L1 deficiency leads to lysosomal dysfunction and alpha-synuclein accumulation. Mov Disord. 34(7):1049-1059.
RAB7L1 represents a potential therapeutic target for Parkinson's disease:
| Agent | Target | Stage | Notes |
|---|---|---|---|
| Small molecule RAB GTPase modulators | RAB7L1 | Discovery | Limited specific modulators |
| Gene therapy | RAB7L1 expression | Preclinical | AAV delivery approaches |
RAB7L1 variations are associated with:
RAB7L1 is a Rab GTPase critical for lysosomal trafficking and autophagy. Its genetic variants increase Parkinson's disease risk. Understanding RAB7L1's role in endolysosomal pathways may lead to new therapeutic strategies for PD and related disorders.
The study of Rab7L1 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
[1] RAB7L1 and Parkinson disease. PMID:25472558